General Information of This Drug (ID: DMCE5DP)

Drug Name
Elesclomol   DMCE5DP
Synonyms
Elesclomol; 488832-69-5; Elesclomol (STA-4783); STA-4783; UNII-6UK191M53P; CHEBI:79369; 6UK191M53P; Propanedioic acid, bis[2-methyl-2-(phenylthioxomethyl)hydrazide]; 1,3-Bis[2-methyl-2-(phenylthioxomethyl)hydrazide]propanedioic acid; N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothioyl)malonohydrazide; J-503879; C19H20N4O2S2; 1-N'-Benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl-oxopropanehydrazidide; Elesclomol [USAN:INN]; elesclomolum
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

7 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Artemisinin + Elesclomol DCLLTBK Artemisinin DD2 (Cell Line: DD2) [2]
Atovaquone + Elesclomol DCYTP28 Atovaquone Hepatoblastoma (Cell Line: HB3) [2]
Elesclomol + Mitomycin DCS38EK Mitomycin Diffuse large B cell lymphoma (Cell Line: TMD8) [2]
Elesclomol + Ibrutinib DCHTMDS Ibrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [2]
Elesclomol + Ruxolitinib DCRYDJ0 Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [3]
MK-3207 + Elesclomol DCSCXOD MK-3207 Hepatoblastoma (Cell Line: HB3) [3]
Proguanil + Elesclomol DCS4LSK Proguanil Hepatoblastoma (Cell Line: HB3) [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DrugCom(s)

References

1 ClinicalTrials.gov (NCT00522834) Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma. U.S. National Institutes of Health.
2 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
3 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976